Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,297.41 -41.65 (-3.11%)
Sutro Biopharma, Inc. (STRO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:14PM EDT. Market open.
| Previous close | 3.5200 |
| Open | 3.5000 |
| Bid | 3.4500 x 100 |
| Ask | 3.4600 x 200 |
| Day's range | 3.4050 - 3.5050 |
| 52-week range | 2.0100 - 6.1300 |
| Volume | |
| Avg. volume | 1,000,180 |
| Market cap | 265.376M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially
The analysts covering Sutro Biopharma, Inc. ( NASDAQ:STRO ) delivered a dose of negativity to shareholders today, by...
- GuruFocus.com
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
Full Year Earnings Reveal Strong Revenue Growth but Operational Challenges Persist
- Zacks
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of 151.22% and 834.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.